|
Market Closed -
Nasdaq
16:00:00 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 3.510 USD | -4.10% |
|
-9.07% | +147.18% |
| 08-19 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
| 08-13 | Edesa Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 | CI |
Company Valuation: Edesa Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 47.43 | - | - |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 172.83% | - | - |
| Enterprise Value (EV) | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 47.43 | 47.43 | 47.43 |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 172.83% | 0% | 0% |
| P/E | -6.71x | -0.88x | -1.51x | -2.31x | -1.94x | -1.77x | -1.7x | -1.71x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.19x | 0x | 0.1x | 0.1x | -0x | -0.42x | 2.12x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 2.04x |
| EV / Revenue | - | - | - | - | - | - | - | 2.04x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.65x | -1.97x | -1.44x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.7 | -7.35 | -2.93 | -1.93 | -1.27 | -1.987 | -2.067 | -2.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 23.26 |
| EBITDA | -23.56 | - | - | - | - | - | - | - |
| EBIT 1 | -23.68 | -18.37 | -9.223 | -7.015 | -7.912 | -17.93 | -24.13 | -32.89 |
| Net income 1 | -13.34 | -17.55 | -8.374 | -6.17 | -7.186 | -17.52 | -23.88 | -32.64 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 51.660 | 6.449 | 4.424 | 4.450 | 2.470 | 3.510 | 3.510 | 3.510 |
| Nbr of stocks (in thousands) | 1,894 | 2,209 | 3,013 | 3,247 | 7,038 | 13,512 | - | - |
| Announcement Date | 12/28/21 | 12/16/22 | 12/15/23 | 12/13/24 | 12/12/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.77x | - | - | - | 47.43M | |
| 20.5x | 7.3x | 14.66x | 1.45% | 70.61B | |
| 27.46x | 7.51x | 23.56x | 0.05% | 51.01B | |
| 33.37x | 6x | 17.96x | 0.97% | 48.1B | |
| 33.47x | 3.25x | 14.03x | -.--% | 42.78B | |
| -19.64x | 203.45x | -20.92x | -.--% | 40.67B | |
| 46.95x | 5.34x | 29.33x | -.--% | 40.3B | |
| 27.18x | 7.73x | 20.09x | 0.42% | 30.59B | |
| 32.53x | 6.94x | 18.03x | -.--% | 28.16B | |
| -14.69x | 5.97x | -7.21x | -.--% | 24.36B | |
| Average | 18.54x | 28.17x | 12.17x | 0.32% | 37.66B | |
| Weighted average by Cap. | 22.22x | 27.60x | 13.22x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EDSA Stock
- Valuation Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
